Updated Key Information Document

RNS Number : 3833Y
FastForward Innovations Limited
08 September 2020
 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

8 September 2020

 

FastForward Innovations Ltd

("FastForward", "FFWD" or the "Company")

 

Updated Key Information Document

 

FastForward Innovations Ltd, the AIM quoted company focused on investing in fast growing, industry leading businesses, is pleased to announce that the Company has prepared an updated Key Information Document ("KID") which can now be viewed on FastForward's website via the following link:  https://bit.ly/2FfTFyU.

 

* ENDS*

 

For further information on the Company please visit www.fstfwd.co   or contact:

 

Ed McDermott / Lance de Jersey

FastForward Innovations Ltd

Email: info@fstfwd.co  

 

James Biddle / Roland Cornish

Beaumont Cornish Limited,

Nomad

 

Tel: +44 (0) 207 628 3396

 

Graham Dickson

Optiva Securities Limited,

Broker

 

Tel: +44 (0) 203 411 1881

 

Susie Geliher / Beth Melluish

St Brides Partners Ltd,

Financial PR

 

Tel: +44 (0)207 236 1177

 

About FastForward Innovations Limited

FastForward Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAUWVSRRNUKRAR
UK 100

Latest directors dealings